Cargando...

Clinical efficacy and safety of rituximab in lupus nephritis

BACKGROUND: Long-term treatment programs with low toxicity represent a therapeutic challenge in lupus nephritis (LN). Although a therapeutic benefit of rituximab (RTX) has been reported in LN patients who have failed conventional treatment, the results are controversial. We aimed to assess the clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drug Des Devel Ther
Autores principales: Zhong, Zhiqing, Li, Hongyan, Zhong, Hongzhen, Zhou, Tianbiao
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6417005/
https://ncbi.nlm.nih.gov/pubmed/30880917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S195113
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!